Legal & General Group Plc Makes New Investment in Azenta, Inc. $AZTA

Key Points

• Legal & General Group Plc acquired 96,123 Azenta shares in the second quarter, worth approximately $2.45 million and representing about 0.22% of the company. Institutional investors and hedge funds collectively own 99.08% of AZTA.
• Azenta reported quarterly earnings of $0.16 per share, exceeding the $0.11 consensus estimate, while revenue of $161.18 million also topped expectations of $149.31 million.
• AZTA shares opened at $31.33, up 0.5%, with analysts holding an average “Hold” rating and a consensus price target of $41.20; Needham raised its target to $37 and maintained a “Buy” rating.

Legal & General Group Plc acquired a new stake in Azenta, Inc. (NASDAQ:AZTA - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 96,123 shares of the company's stock, valued at approximately $2,453,000. Legal & General Group Plc owned approximately 0.22% of Azenta at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of AZTA. Osaic Holdings Inc. increased its holdings in shares of Azenta by 44.9% in the second quarter. Osaic Holdings Inc. now owns 1,242 shares of the company's stock valued at $39,000 after purchasing an additional 385 shares in the last quarter. CWM LLC lifted its holdings in Azenta by 27.3% during the 4th quarter. CWM LLC now owns 1,822 shares of the company's stock worth $61,000 after buying an additional 391 shares in the last quarter. Empowered Funds LLC lifted its holdings in Azenta by 10.5% during the 1st quarter. Empowered Funds LLC now owns 6,482 shares of the company's stock worth $225,000 after buying an additional 618 shares in the last quarter. Neuberger Berman Group LLC boosted its position in Azenta by 8.9% in the 4th quarter. Neuberger Berman Group LLC now owns 8,379 shares of the company's stock valued at $279,000 after buying an additional 684 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Azenta by 0.8% in the 3rd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 82,534 shares of the company's stock valued at $2,335,000 after buying an additional 686 shares during the period. 99.08% of the stock is currently owned by institutional investors and hedge funds.

Azenta Stock Up 0.5%

Shares of AZTA stock opened at $31.33 on Friday. Azenta, Inc. has a 12-month low of $15.93 and a 12-month high of $41.73. The firm has a fifty day moving average of $29.73 and a 200-day moving average of $25.28. The firm has a market capitalization of $1.37 billion, a price-to-earnings ratio of -11.35 and a beta of 1.39.

Azenta (NASDAQ:AZTA - Get Free Report) last posted its earnings results on Tuesday, August 4th. The company reported $0.16 earnings per share for the quarter, topping the consensus estimate of $0.11 by $0.05. Azenta had a positive return on equity of 1.18% and a negative net margin of 20.63%.The firm had revenue of $161.18 million for the quarter, compared to analyst estimates of $149.31 million.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on AZTA. Weiss Ratings raised Azenta from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Wednesday, August 26th. Needham & Company LLC lifted their price objective on Azenta from $33.00 to $37.00 and gave the stock a "buy" rating in a research report on Wednesday, August 5th. Four investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Azenta currently has an average rating of "Hold" and an average target price of $41.20.

About Azenta

Azenta, Inc NASDAQ: AZTA is a life sciences technology company specializing in sample management, cryogenic storage and genomic services for research and clinical applications. Formerly the Life Sciences division of Brooks Automation, Azenta provides integrated solutions that enable customers to store, track and analyze biological samples with high levels of automation, data integrity and efficiency. Its offerings span automated storage systems, biorepository management software and end‐to‐end sample tracking workflows.

In addition to hardware and informatics platforms for sample storage, Azenta's Genomics business delivers next‐generation sequencing (NGS), DNA synthesis, and molecular biology services.

Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source